Research Article
Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis
Table 3
Univariate and multivariate Cox regression analyses for overall survival in patients with adenocarcinoma of oesophagogastric junction (unmatched complete datasets).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJCC: American Joint Committee on Cancer; SIRI: systemic inflammation response index; PLR: platelet lymphocyte ratio; NLR: neutrophil lymphocyte ratio; MLR: monocyte lymphocyte ratio; HR: hazard ratio; CI: confidence interval; Ref.: reference. aThe variables (grade, tumour size, TNM stage, vascular invasion, and SIRI) were tested in a multivariate analysis. bThe variables (grade, tumour size, TNM stage, vascular invasion, and NLR) were tested in a multivariate analysis. cThe variables (grade, tumour size, TNM stage, vascular invasion, and PLR) were tested in a multivariate analysis. dThe variables (grade, tumour size, TNM stage, vascular invasion, and MLR) were tested in a multivariate analysis. |